OIP5 and Sepsis: We identified that the lncRNA OIP5-AS1-mediated ceRNA pair could represent a novel and highly promising diagnostic biomarker and therapeutic target for sepsis and four drugs that might be used to reduce inflammatory responses in sepsis treatment.